JNJong Hyun Nho

Jong Hyun Nho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jong Hyun Nho has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Genotoxicity of Gagam-Jokyung-tang

    by Seong Min Hwang, Sung Young Cho, Su Yeong Kim, Jong Hyun Nho

    Objectives: This study was conducted to evaluate the genotoxic potential of Gagam-jokyung-tang.Methods: Genotoxicity was assessed using a bacterial reverse mutation test (Ames test), an in vitro mammalian chromosomal aberration test, and an in vivo micronucleus test. The bacterial reverse mutation test was performed using Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537 and Escherichia coli WP2uvrA in the presence and absence of metabolic activation. The chromosomal aberration test was conducted in cultured mammalian cells under both metabolic activation and non-activation conditions. The micronucleus test was performed in ICR mice, and the frequency of micronucleated polychromatic erythrocytes in bone marrow cells was evaluated following oral administration of the test substance.Results: The test substance did not induce an increase in revertant colonies in any of the bacterial strains tested. In the chromosomal aberration test, no significant increase in structural chromosomal aberrations was observed compared with the negative control. In the micronucleus test, the frequency of micronucleated polychromatic erythrocytes was not increased in the treated groups, and no changes in the PCE/(PCE+NCE) ratio were observed.Conclusions: These results indicate that Gagam-jokyung-tang freeze-dried extract did not exhibit genotoxic potential under the conditions of the present study and may provide basic safety data for the development and safety evaluation of Gagam-jokyung-tang preparations.

  • Open Access

    Genotoxicity and acute toxicity of Hyunburikyung-tang: assessing the safety of prescribing traditional Korean medicine for dysmenorrhea

    by Sung-Young Jo, Sung-Min Hwang, Jun-Sub Kim, Su-Yeong Kim, Kyeong-Wan Woo, Hyun-Woo Cho, Jong-Hyun Nho

    Hyunburikyung-tang exerts an anti-inflammatory effect by suppressing pro-inflammatory cytokines and prostaglandin E2 and is clinically used to improve dysmenorrhea in Korea. It contains various medicinal plants including peach seeds (Prunus persica Batsch) and safflower (Carthamus tinctorius Linn). Peach seeds contain amygdalin, which demonstrates teratogenic effects, and safflower is reported to cause reproductive toxicity and teratogenic effects in mice. These findings raise concerns regarding the teratogenic potential of these substances. A potential correlation exists between genotoxicity and teratogenicity. Genotoxic substances can damage DNA and cause mutations or chromosomal abnormalities, which may result in developmental malformations. Therefore, we aimed to assess whether Hyunburikyung-tang causes acute toxicity or genotoxicity. Seven-week-old male and female Sprague-Dawley rats were orally administered a single dose of Hyunburikyung-tang to assess acute toxicity (625, 1,250, or 2,500 mg/kg). Body weight measurements, general symptom observations, and autopsy examinations were used to confirm toxic responses according to Toxicity Test Guidelines for Drugs, etc. [No. 2022-18, the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea]. Genotoxicity assessment was conducted with bacteria, cells, and mice, according to the organization for economic cooperation and development test guidelines (TG 471, TG473, and TG474). Regarding the acute toxicity assessment, oral administration of Hyunburikyung-tang at doses up to 2,500 mg/kg in male and female rats did not result in body weight loss (p > 0.05), and general symptoms including death, weakening, irregular respiration etc. was did not observed. Upon necropsy, no visible damage was observed in major organs such as the liver and heart. Hyunburikyung-tang not only showed no mutagenic activity in the Bacterial reverse mutation test, but also did not significantly increase the incidence of chromosomal aberrations or the frequency of micronuclei in bone marrow (p > 0.05). Moreover, in the in vitro test, no genotoxicity was induced when metabolic activation by rat liver fractions was applied to mimic hepatic metabolism. Our findings suggested that Hyunburikyung-tang does not induce acute toxicity or genotoxicity. Nevertheless, follow-up research should be conducted to confirm toxicity caused by repeated administration and adverse effects on embryonic cells.


  • Open Access

    Safety Evaluation of the Liriope platyphylla Water Extract by Bacterial Reverse Mutation Test and Acute Oral Toxicity Study

    by Seong Min Hwang, Sung Young Cho, Su Yeong Kim, Jong Hyun Nho

    Objectives: Liriope platyphylla has been traditionally used in Korean medicine for relieving cough, reducing lung heat, and nourishing the yin. However, scientific data regarding the safety of its water extract reamins insufficient. This study was conducted to evaluate the genotoxicity and acute oral toxicity of the Liriope platyphylla water extract through a bacterial reverse mutation test and a single-dose oral toxicity study in rats.Methods: This study evaluated the genotoxic and acute oral toxicity of the Liriope platyphylla water extract. A bacterial reverse mutation assay (Ames test) was conducted using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537, as well as Escherichia coli WP2 uvrA, both with and without metabolic activation (S9 mix). Additionally, a single-dose oral toxicity study was performed in Sprague-Dawley rats according to OECD Test Guideline 423.Results: No increase in revertant colonies or dose-dependent mutagenicity was observed in any strain, regardless of the presence of S9 mix. In the acute oral toxicity test, no mortality, clinical signs, or pathological changes were found at doses up to 2,000 mg/kg.Conclusions: These results suggest that the Liriope platyphylla water extract is non-mutagenic and does not exhibit acute oral toxicity after single-dose administration, supporting its potential safety as a herbal resource for further development


  • Open Access

    Non-clinical safety evaluation of Mangeum-tang

    by Sung-Min Hwang, Sung-Young Jo, Su-Yeong Kim, Jun-Sub Kim, Hyun-Woo Cho, Jong-Hyun Nho

    In South Korea, the traditional use of Korean medicine is recognized by the government, with efforts being made to expand its inclusion in health insurance. However, unlike pharmaceutical drugs, traditional medicines are used in clinical practice without proper non-clinical and clinical trial validation, raising criticism and concerns. Mangeum-tang is commonly used for treating sequelae from stroke and neuralgia. The rhizome of Cnidium officinale MAKINO, included in Mangeum-tang, is known to reduce embryonic growth and development in rats and induce mild limb malformations, raising safety concerns. The causes of malformations are diverse, often linked to genotoxicity, prompting toxicity investigations. In vitro, Mangeum-tang did not induce genetic mutations or chromosomal aberration, and in vivo, it did not cause micronucleus formation or acute toxicity in hematopoietic cells. Therefore, Mangeum-tang does not appear to induce acute toxicity or genotoxicity. However, the studies conducted were short-term, and toxicity from repeated administration has not been confirmed. To ensure the safety of Mangeum-tang, further studies, including repeated-dose toxicity tests, carcinogenicity tests, reproductive toxicity tests, and additional research on the genotoxicity of Cnidium officinale MAKINO, are necessary.


  • Open Access

    Safety assessment of Gami-daebo-tang gagambang used for treating stroke sequelae

    by Sung-Min Hwang, Sung-Young Jo, Su-Yeong Kim, Jong-Hyun Nho

    Objectives: This study aimed to investigate wheter Gami-daebo-tang gagambang, commonly used for treating stroke sequelae, induces acute toxicity or genetoxicity.Methods: Gami-daebo-tang gagambang contains that the root of Angelica gigas Nakai inducing acute headache and weakness, and the rhizome of Cnidium officinale MAKINO, an herb with potential teratogenicity. Teratogenicity is closely associated with genotoxicity. We analyzed whether Gami-daebo-tang gagambang induces acute toxicity and genotoxicity in accordance with Korean non-clinical test standards and OECD test guidelines TG471, TG473, TG474.Results: When male and female rats were given a single dose of Gami-daebo-tang gagambang, no toxic effects or organ damage were observed at dosages reaching 2,500 mg/kg. The bacterial reverse mutation assay showed no evidence of DNA mutations at concentrations up to 5,000 μg/plate. In vitro studies indicated that Gami-daebo-tang gagambang did not cause structural or numerical chromosomal aberrations at concentrations as high as 2,000 μg/mL. Moreover, animal studies demonstrated that the substance did not induce bone marrow toxicity or the formation of micronuclei in erythrocytes at doses up to 2,000 mg/kg.Conclusions: The studies conducted with different models showed that Gami-daebo-tang gagambang did not cause acute toxicity or genotoxicity. This study provides evidence for the safety of Gami-daebo-tang gagambang in terms of acute toxicity and genotoxicity, supporting its potential safe application in treating stroke sequelae.


  • Open Access

    Acute toxicity and genotoxicity assessment of Ligigeopoong-san

    by Sung-Young Jo, Sung-Min Hwang, Su-Yeong Kim, Jun-Sub Kim, Kyeong-Wan Woo, Hyun-Woo Cho, Jong-Hyun Nho

    Objectives: This study aimed to investigate whether Ligigeopoong-san induces acute toxicity and genotoxicityMethods: Ligigeopoong-san contains the rhizome of Cnidium officinale MAKINO, an herb with potential teratogenicity. Teratogenicity is closely associated with genotoxicity. We analyzed whether Ligigeopoong-san induces acute toxicity and genotoxicity using various experimental models in accordance with Korean non-clinical test standards for pharmaceuticals and OECD test guidelines.Results : When Ligigeopoong-san was administered as a single dose to male and female rats, no toxic reactions, including organ damage, were observed at doses up to 2,500 mg/kg. In the bacterial reverse mutation test, no DNA mutations were detected at concentrations up to 5,000 μg/plate. In cell models, Ligigeopoong-san did not induce structural or numerical chromosomal aberrations at concentrations up to 2,000 μg/mL. Additionally, in animal studies, it did not cause bone marrow toxicity or form micronuclei in erythrocytes at doses up to 2,000 mg/kg.Conclusions : The experiments using various models demonstrated that Ligigeopoong-san did not induce acute toxicity or genotoxicity.


  • Improvement Effect of the Water Extract from the Root of Cirsium japonicum var. ussuriense on Type II Collagen-induced Rheumatoid Arthritis Animal Models

    by Jong Hyun Nho, Hyeun Joo Lee, E Na Lee, Kyeong Wan Woo, Ji Hun Jang, Sun Ra Kim, Hyun Woo Cho, Se Eung Noh, Ho Kyung Jung

    Background: The roots of Cirsium japonicum var. ussuriense (RCJ) have been used as traditional medicine in Korea for hematuria and hematemesis. These extracts exert anti-oxidative and anti-inflammatory effects by scavenging for free radical and regulating the inflammatory response. However, the effect of RCJ on rheumatoid arthritis (RA) has not been elucidated. Thus, we evaluated the water extract of RCJ (WRCJ) using type II collagen-induced RA models. Methods and Results: RA was induced by immunization with type II collagen. All experimental materials were orally administered daily for three weeks. The positive control group was administered with 0.2 ㎎/㎏ methotrexate (n = 7), while the experimental group was administered with WRCJ (100 or 500 ㎎/㎏, n = 7). Serum levels of TNF-alpha, Interleukin 6 (IL-6), and type II collagen IgG (CII) were measured using ELISA. Administration of 500 ㎎/㎏ WRCJ decreased the levels of TNF-alpha, IL-6, and CII. Moreover, WRCJ treatment diminished swelling of hind legs and infiltration of inflammatory cells in RA models’ synovial membrane. Conclusions: These results indicate that WRCJ could improve RA, reduce inflammatory indicators and synovial inflammation. However, further experiments are required to determine how WRCJ can influence the signal transduction pathway in RA.


  • A 13-week repeated oral dose toxicity evaluation and a 4-week recovery evaluation of the Sam So Eum (SSE) in male and female rats

    by Jong-Hyun Nho, Hyun-Joo Lee, Seon-Yu Lee, Ji-Hun Jang, Beo-Deul Yang, Ji-Hyun Jeong, Guk-Yeo Lee, Hyun-Woo Cho, Jong-Choon Kim, Ho-Kyung Jung


  • Anti-hyperglycemic Effect of Bangpungtongseong-san on Type II Diabetes Animal Models

    by Moon Hee Ko, Hyun Woo Cho, Jong Hyun Nho

    Background: Type II diabetes is considered as one of the common diseases. Bangpungtongseongsan (BPS) has been used as a traditional medicine for treating obesity and hypertension in Korea. According to previous reports, it has anti-obesity, anti-chronic asthma, anti-oxidant, and antiinflammatory properties. However, the effects of BPS on type II diabetes have not yet been elucidated. Thus, in this sutudy, we evaluated the water extracts of BPS using type II diabetes animal models. Methods and Results: Each group was orally administered with BPS (170, 850 and 1,700 ㎎/㎏) for approximately 13 weeks. A mixture of 150 ㎎/㎏ metformin and 10 ㎎/㎏ sitagliptin (MS) was used as a positive control. The glycated hemoglobin (HbA1c) and glucose levels, and hematological parameters including blood urine nitrogen, creatinine, low density lipoprotein and total cholesterol, were measured using blood samples. Treatment with 170 ㎎/㎏ BPS decreased the HbA1c and glucose levels in blood without affecting the weights of the animals. However, threatment with 1,700 ㎎/㎏ BPS reduced the weights and fatty liver, and increased the blood glucose level in type II diabetes animal models Conclusions: These results indicate that a low dose of BPS for 13 weeks, which reduces HbA1c and blood glucose levels, could be used for the treatment of type II diabetes. However, further studies are required to elucidate how active ingredients of BPS influence HbA1c and glucose levels in blood.

  • Safety Evaluation Test of Galgeun-tang Applied to Guidelines for the Testing of Chemicals

    by Jong Hyun Nho, Ji Hun Jang, Mu Jin Lee, Beodul Yang, Kyeong Wan Woo, Hyun Joo Lee, A Hyeon Kim, Mi Ok Sim, Hyun Woo Cho, Ho Kyung Jung

    Background: Galgeun-tang used in traditional Korean medicine, is a mixture of the medicinal plants Cinnamomi Ramulus, Ephedrae Herba and Puerariae Radix, and has been prescribed for the treatment of various ailments, including fever. Although the use of traditional medicinal herbs to treat diseases has recently increased, their safety and toxicity profiles incompletely elucidated. Thus, we evaluated Galgeun-tang's toxicity in male and female Sprague-Dawley rats. Methods and Results: Galgeun-tang (1,000, 2,000 and 4,000 mg/kg) was orally administered to rats for 13 weeks, and then, they were maintained for 4 weeks without administration (recovery period). Their clinical signs, and hematological and urinary properties, were monitored. The results showed that Galgeun-tang administeration slightly increased serum creatinine, urea nitrogen and, aspartate aminotransferase levels. Additionally, 2,000 and 4,000 mg/kg Galgeun-tang significantly increased urinary bilirubn and protein levels of male and female rats, which were restored during the recovery period. Conclusions: The no-observed-adverse-effect level of orally administered Galgeun-tang was 4,000 mg/kg in both female and male rats, and no target organs were identified. In addition, 400 mg/kg was found to be the no-observed-effect level for toxicity under the study conditions.